The filing removes immediate delisting risk, but the strict one-year monitoring period means any future bid price dip below $1.00 could quickly lead to delisting proceedings. Traders should monitor LNAI's share price closely — any sustained weakness near $1.00 increases delisting risk significantly given the limited cure rights.
Price Chart
Executive Summary
Lunai Bioworks received a letter from Nasdaq confirming it has regained compliance with the minimum $1.00 bid price rule after a Panel extension. The company is now subject to a mandatory one-year Panel monitor with limited cure rights if it falls out of compliance again.
Key Facts
- Nasdaq confirmed Lunai Bioworks regained compliance with the $1.00 minimum bid price rule (Listing Rule 5550(a)(2)) on June 11, 2026.
- The company had received Panel decisions and extension letters on April 20, 2026 and May 12, 2026.
- A mandatory one-year Panel monitor begins immediately. If the company falls out of compliance during monitoring, it cannot submit a new plan of compliance and will face delisting with a right to a new hearing.
- Current market capitalization is approximately $12 million, indicating a micro-cap biotech.
Financial Impact
No financial figures are disclosed in the filing. The event relates solely to listing compliance; no operational or financial metrics are mentioned.
Risk Factors
- If the stock price falls below $1.00 during the one-year monitoring period, Nasdaq will issue a delist determination with no plan-of-compliance option, only a hearing stay.
- Micro-cap biotech with $12M market cap is inherently volatile and faces ongoing funding/liquidity risks.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001731122-26-000865 |
| Document: 0001731122-26-000865-index-headers.html | 0001731122-26-000865 |
| Document: 0001731122-26-000865-index.html | 0001731122-26-000865 |
| Document: 0001731122-26-000865.txt | 0001731122-26-000865 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 22, 2026 3d ago | 8-K | $0.2946 $0.2750 | ▲ +6.65% | ▲ +7.36% | $0.2750 (+6.65%) |
Oct 15, 2026 10d ago | SC 13D/A | $0.6800 $0.4720 | ▲ +30.59% | ▲ +31.01% | $0.2750 (+59.56%) |
Oct 9, 2026 17d ago | 8-K | $1.23 $1.11 | ▲ +9.76% | ▲ +9.70% | $0.2750 (+77.64%) |
Sep 29, 2026 27d ago | NT 10-K | $1.47 $1.38 | ▲ +6.12% | ▲ +6.30% | $0.2750 (+81.29%) |
Jun 17, 2026 18w ago | 8-K | $3.78 $4.15 | ▲ +9.79% | ▲ +10.10% | $0.2750 (−92.72%) |
Jun 16, 2026 18w ago | 8-K | $4.00 $3.78 | ▼ −5.50% | ▼ −6.28% | $0.2750 (−93.12%) |
May 20, 2026 22w ago | 8-K | $1.80 $2.32 | ▼ −28.89% | ▼ −28.69% | $0.2750 (+84.72%) |
May 1, 2026 25w ago | 8-K | $2.60 $2.50 | ▼ −3.88% | ▼ −4.68% | $0.2750 (−89.41%) |
Apr 28, 2026 25w ago | DEFA14A | $2.66 $2.64 | ▼ −0.90% | ▼ −1.92% | $0.2750 (−89.68%) |
Mar 5, 2026 33w ago | 8-K | $1.86 $1.76 | ▲ +5.25% | ▲ +6.10% | $0.2750 (+85.20%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers